Data Collection Protocol for Patients With Von Hippel Lindau Disease
Start Date
8/24/2023
Completion Date
12/31/2026
Summary
To collect information from patients with vHL disease. Information collected will include data on the status of the disease, any surgeries or therapies patients have received for vHL disease, and quality of life.
Detailed Description
Primary Objectives: * Obtain prospective and retrospective data on lesion development, surgical history and systemic therapy use in patients with vHL disease * Assess genotype-phenotype correlation between VHL mutation type and patterns of lesion development * Assess genotype-phenotype correlation for response to belzutifan in an organ-specific manner Secondary Objectives: --Obtain quality of life data in patients with vHL disease
Eligibility Criteria
Age Range: 18 years to No maximum
Conditions
Locations
M D Anderson Cancer Center
Houston, Texas 77030
United States